Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

Estimated marginal means for changes in outcome parameters A, B, C, D. by Benjamin Udoka Nwosu (476930)

Site-specific evolutionary rates increase with distance to a catalytic residue in 80% of residues. by Benjamin R. Jack (2637040)

Mean posterior estimates for parameters of interest for each simulated dataset varying across date resolution. by Leo A. Featherstone (21078333)

Expected change in the mass-specific fecundity (in percentage) for a female of a given mass at a given latitude under predicted climate change scenarios. by Mariana Álvarez-Noriega (14275263)

“…<p>The colours show the reduction in the percentage change in mass-specific fecundity, with the largest increase in yellow and the largest decrease in black. …”

Mean internal space gap. by Mizuki Kakizawa (22574740)

Statin decreases <i>H</i>. <i>pylori</i> CagA translocation/phosphorylation in gastric epithelial cells. by Chun-Jung Lin (216667)

Data_Sheet_1_Dark triad personality traits are associated with decreased grey matter volumes in ‘social brain’ structures.docx by Artem Myznikov (11562496)

“…</p>Methods<p>We performed a clustering analysis of the Dirty Dozen Dark Triad questionnaire scores of 129 healthy subjects using the k-means method. …”

Purmorphamine decreases FSK-directed cAMP production in a cilium-independent manner. by Lan Ho Wei (5688020)

A confidential scheme using a symmetric key [3]. by John Kwao Dawson (14593666)